

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 8.67685264 |
| 2 | ethanol oxidation (GO:0006069) | 8.17685023 |
| 3 | primary alcohol catabolic process (GO:0034310) | 7.80755370 |
| 4 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 7.26446927 |
| 5 | regulation of female gonad development (GO:2000194) | 6.84962597 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.42601151 |
| 7 | intestinal absorption (GO:0050892) | 6.41351172 |
| 8 | ethanol metabolic process (GO:0006067) | 6.34535811 |
| 9 | NADH metabolic process (GO:0006734) | 5.74069187 |
| 10 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.28879250 |
| 11 | regulation of bile acid biosynthetic process (GO:0070857) | 5.18452020 |
| 12 | drug metabolic process (GO:0017144) | 4.93703997 |
| 13 | antibacterial humoral response (GO:0019731) | 4.90351388 |
| 14 | vocalization behavior (GO:0071625) | 4.83801691 |
| 15 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.81937870 |
| 16 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.79367510 |
| 17 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.79367510 |
| 18 | endocrine process (GO:0050886) | 4.79367510 |
| 19 | regulation of triglyceride catabolic process (GO:0010896) | 4.78892016 |
| 20 | lipoprotein transport (GO:0042953) | 4.70539929 |
| 21 | fructose metabolic process (GO:0006000) | 4.65720940 |
| 22 | antimicrobial humoral response (GO:0019730) | 4.61684496 |
| 23 | urea metabolic process (GO:0019627) | 4.60138418 |
| 24 | drug catabolic process (GO:0042737) | 4.55021474 |
| 25 | hormone catabolic process (GO:0042447) | 4.53323054 |
| 26 | urea cycle (GO:0000050) | 4.50553840 |
| 27 | diacylglycerol metabolic process (GO:0046339) | 4.50450183 |
| 28 | regulation of cellular extravasation (GO:0002691) | 4.41801687 |
| 29 | cellular glucuronidation (GO:0052695) | 4.40571489 |
| 30 | regulation of systemic arterial blood pressure (GO:0003073) | 4.38908951 |
| 31 | renal system process involved in regulation of blood volume (GO:0001977) | 4.28298838 |
| 32 | glucuronate metabolic process (GO:0019585) | 4.28287067 |
| 33 | uronic acid metabolic process (GO:0006063) | 4.28287067 |
| 34 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.26727040 |
| 35 | flavonoid metabolic process (GO:0009812) | 4.26415582 |
| 36 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.25010295 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.14942824 |
| 38 | regulation of cGMP biosynthetic process (GO:0030826) | 4.11879686 |
| 39 | exogenous drug catabolic process (GO:0042738) | 4.09783272 |
| 40 | phospholipid efflux (GO:0033700) | 4.05486311 |
| 41 | extracellular negative regulation of signal transduction (GO:1900116) | 4.03235711 |
| 42 | extracellular regulation of signal transduction (GO:1900115) | 4.03235711 |
| 43 | opioid receptor signaling pathway (GO:0038003) | 4.02986708 |
| 44 | bile acid and bile salt transport (GO:0015721) | 4.00140081 |
| 45 | plasma lipoprotein particle assembly (GO:0034377) | 3.95892033 |
| 46 | behavioral response to ethanol (GO:0048149) | 3.93867533 |
| 47 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.93106326 |
| 48 | response to histamine (GO:0034776) | 3.92072099 |
| 49 | multicellular organismal water homeostasis (GO:0050891) | 3.88176894 |
| 50 | peptide hormone processing (GO:0016486) | 3.87542658 |
| 51 | peptide catabolic process (GO:0043171) | 3.86332479 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85445034 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85445034 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.84593833 |
| 55 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.83653830 |
| 56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.83118409 |
| 57 | alkaloid metabolic process (GO:0009820) | 3.81642017 |
| 58 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.77063710 |
| 59 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.76180483 |
| 60 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.73596548 |
| 61 | negative regulation of complement activation (GO:0045916) | 3.67867918 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.63855712 |
| 63 | regulation of cholesterol esterification (GO:0010872) | 3.63731139 |
| 64 | virion attachment to host cell (GO:0019062) | 3.62421733 |
| 65 | adhesion of symbiont to host cell (GO:0044650) | 3.62421733 |
| 66 | protein-lipid complex assembly (GO:0065005) | 3.62071711 |
| 67 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.58505626 |
| 68 | lipoprotein metabolic process (GO:0042157) | 3.57297243 |
| 69 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.56839648 |
| 70 | digestion (GO:0007586) | 3.54755144 |
| 71 | positive regulation of lipid catabolic process (GO:0050996) | 3.54521332 |
| 72 | long term synaptic depression (GO:0060292) | 3.54116702 |
| 73 | digestive system process (GO:0022600) | 3.53915681 |
| 74 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.51564117 |
| 75 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.48928520 |
| 76 | complement activation, classical pathway (GO:0006958) | 3.47227953 |
| 77 | arginine metabolic process (GO:0006525) | 3.46385599 |
| 78 | cardiac conduction (GO:0061337) | 3.45015574 |
| 79 | cellular response to ammonium ion (GO:0071242) | 3.44275250 |
| 80 | cGMP-mediated signaling (GO:0019934) | 3.41582389 |
| 81 | actin filament depolymerization (GO:0030042) | 3.38047029 |
| 82 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.37614017 |
| 83 | positive regulation of pseudopodium assembly (GO:0031274) | 3.36995108 |
| 84 | transmission of nerve impulse (GO:0019226) | 3.33955710 |
| 85 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.33561166 |
| 86 | multicellular organismal signaling (GO:0035637) | 3.32759996 |
| 87 | regulation of cGMP metabolic process (GO:0030823) | 3.32158716 |
| 88 | sulfate transmembrane transport (GO:1902358) | 3.31653349 |
| 89 | locomotory exploration behavior (GO:0035641) | 3.30450665 |
| 90 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.29747134 |
| 91 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.28296815 |
| 92 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.27817500 |
| 93 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.27575649 |
| 94 | regulation of respiratory burst (GO:0060263) | 3.26214378 |
| 95 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.26204862 |
| 96 | renal absorption (GO:0070293) | 3.26046360 |
| 97 | protein-lipid complex remodeling (GO:0034368) | 3.23157309 |
| 98 | macromolecular complex remodeling (GO:0034367) | 3.23157309 |
| 99 | plasma lipoprotein particle remodeling (GO:0034369) | 3.23157309 |
| 100 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.22105318 |
| 101 | vitamin A metabolic process (GO:0006776) | 3.21016499 |
| 102 | water homeostasis (GO:0030104) | 3.16884377 |
| 103 | bile acid metabolic process (GO:0008206) | 3.16715956 |
| 104 | high-density lipoprotein particle remodeling (GO:0034375) | 3.15453567 |
| 105 | adhesion of symbiont to host (GO:0044406) | 3.15190971 |
| 106 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.14478515 |
| 107 | glomerular filtration (GO:0003094) | 3.12622950 |
| 108 | dopamine receptor signaling pathway (GO:0007212) | 3.12236524 |
| 109 | synaptic vesicle exocytosis (GO:0016079) | 3.10821888 |
| 110 | regulation of vitamin metabolic process (GO:0030656) | 3.10810894 |
| 111 | homocysteine metabolic process (GO:0050667) | 3.10504739 |
| 112 | retinoic acid metabolic process (GO:0042573) | 3.10153324 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.09421530 |
| 114 | membrane hyperpolarization (GO:0060081) | 3.08572842 |
| 115 | drug transport (GO:0015893) | 3.05539163 |
| 116 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05283892 |
| 117 | glutamate secretion (GO:0014047) | 3.05099655 |
| 118 | transcytosis (GO:0045056) | 3.04621684 |
| 119 | glycolipid catabolic process (GO:0019377) | 3.03783061 |
| 120 | synaptic vesicle maturation (GO:0016188) | 3.03639973 |
| 121 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.03086505 |
| 122 | regulation of pseudopodium assembly (GO:0031272) | 3.02421313 |
| 123 | glycosphingolipid catabolic process (GO:0046479) | 3.00949493 |
| 124 | auditory receptor cell differentiation (GO:0042491) | 3.00702660 |
| 125 | complement activation, alternative pathway (GO:0006957) | 2.99468620 |
| 126 | * O-glycan processing (GO:0016266) | 2.96851096 |
| 127 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.96777840 |
| 128 | negative regulation of hormone metabolic process (GO:0032351) | 2.96516602 |
| 129 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.96516602 |
| 130 | protein-lipid complex subunit organization (GO:0071825) | 2.96214718 |
| 131 | long-term synaptic potentiation (GO:0060291) | 2.95104375 |
| 132 | regulation of keratinocyte proliferation (GO:0010837) | 2.94757156 |
| 133 | renal filtration (GO:0097205) | 2.92133680 |
| 134 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.92073447 |
| 135 | regulation of female receptivity (GO:0045924) | 2.91847550 |
| 136 | cellular response to reactive nitrogen species (GO:1902170) | 2.90824276 |
| 137 | drug transmembrane transport (GO:0006855) | 2.90543616 |
| 138 | negative regulation of protein activation cascade (GO:2000258) | 2.90234506 |
| 139 | cellular response to nitric oxide (GO:0071732) | 2.89805845 |
| 140 | synaptic transmission, glutamatergic (GO:0035249) | 2.89476754 |
| 141 | positive regulation of respiratory burst (GO:0060267) | 2.88963446 |
| 142 | vitamin transport (GO:0051180) | 2.87432103 |
| 143 | epithelial structure maintenance (GO:0010669) | 2.86858172 |
| 144 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.86399602 |
| 145 | complement activation (GO:0006956) | 2.85984019 |
| 146 | omega-hydroxylase P450 pathway (GO:0097267) | 2.85696182 |
| 147 | female mating behavior (GO:0060180) | 2.84706680 |
| 148 | regulation of guanylate cyclase activity (GO:0031282) | 2.81416431 |
| 149 | receptor recycling (GO:0001881) | 2.80811992 |
| 150 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.80178153 |
| 151 | adenosine receptor signaling pathway (GO:0001973) | 2.80110802 |
| 152 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.79039681 |
| 153 | neuron-neuron synaptic transmission (GO:0007270) | 2.78180064 |
| 154 | cell communication involved in cardiac conduction (GO:0086065) | 2.76397384 |
| 155 | cellular potassium ion homeostasis (GO:0030007) | 2.75906388 |
| 156 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.75638442 |
| 157 | sialylation (GO:0097503) | 2.74784249 |
| 158 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.74541090 |
| 159 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.73989173 |
| 160 | glutamate receptor signaling pathway (GO:0007215) | 2.73904632 |
| 161 | neurotransmitter secretion (GO:0007269) | 2.73508247 |
| 162 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.73312468 |
| 163 | neuronal action potential propagation (GO:0019227) | 2.73272428 |
| 164 | cardiovascular system development (GO:0072358) | 2.70410338 |
| 165 | atrioventricular valve morphogenesis (GO:0003181) | 2.69549932 |
| 166 | intestinal epithelial cell development (GO:0060576) | 2.67850543 |
| 167 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.66633753 |
| 168 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.66633753 |
| 169 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.66334801 |
| 170 | sulfate transport (GO:0008272) | 2.65923232 |
| 171 | valine metabolic process (GO:0006573) | 2.64117334 |
| 172 | behavioral response to pain (GO:0048266) | 2.63029225 |
| 173 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.62237363 |
| 174 | retinol metabolic process (GO:0042572) | 2.60184325 |
| 175 | negative regulation of receptor activity (GO:2000272) | 2.59374144 |
| 176 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.58747887 |
| 177 | bicarbonate transport (GO:0015701) | 2.56177950 |
| 178 | vitamin transmembrane transport (GO:0035461) | 2.54812540 |
| 179 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.54466329 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.53765052 |
| 181 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.52538748 |
| 182 | regulation of sodium ion transport (GO:0002028) | 2.51827197 |
| 183 | desmosome organization (GO:0002934) | 2.50176656 |
| 184 | negative regulation of humoral immune response (GO:0002921) | 2.49968530 |
| 185 | neurotransmitter catabolic process (GO:0042135) | 2.49863027 |
| 186 | regulation of synaptic plasticity (GO:0048167) | 2.48914393 |
| 187 | establishment of skin barrier (GO:0061436) | 2.47800305 |
| 188 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.47555159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.82973311 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.27395937 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.89116044 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86945525 |
| 5 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.79667086 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74065621 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62234876 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57252196 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.38695939 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37031747 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.36918477 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35188443 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.32333678 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.23474671 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.23474671 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21226452 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19598941 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.14395165 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.12863400 |
| 20 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.11408120 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11139344 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.10079572 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.06048796 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05389874 |
| 25 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.02792394 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.02606575 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02017471 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.01104805 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00748042 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.97610493 |
| 31 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96522519 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.92471200 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.90374385 |
| 34 | TP53_16413492_ChIP-PET_HCT116_Human | 1.89254577 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.88422781 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.84517027 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84412001 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82063345 |
| 39 | RXR_22108803_ChIP-Seq_LS180_Human | 1.79957267 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78846099 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74293222 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71848470 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70138824 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69651796 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68895556 |
| 46 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.67712623 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66301221 |
| 48 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.65741248 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.64748792 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.64289182 |
| 51 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62116635 |
| 52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59295045 |
| 53 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.57777204 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57332220 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55784399 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55142242 |
| 57 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.52915849 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48855906 |
| 59 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47372719 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.46344644 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43442517 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.42710665 |
| 63 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35964928 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34920050 |
| 65 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32236204 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29653839 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26060843 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25386352 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25102285 |
| 70 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25093149 |
| 71 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24123522 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23722241 |
| 73 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21087658 |
| 74 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.20848802 |
| 75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19786017 |
| 76 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18455744 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17481347 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16550625 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16528826 |
| 80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16231442 |
| 81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.15797568 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.15266344 |
| 83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14276949 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13624627 |
| 85 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13226560 |
| 86 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12969331 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12969331 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11754195 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.11500322 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11003287 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10939568 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09761463 |
| 93 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09706313 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08077375 |
| 95 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07942517 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07788971 |
| 97 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07519879 |
| 98 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.07490424 |
| 99 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.04816362 |
| 100 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03675250 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03386848 |
| 102 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03026151 |
| 103 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02333792 |
| 104 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02273526 |
| 105 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02083362 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.01467175 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00004660 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99942105 |
| 109 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99000529 |
| 110 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.98983759 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98981132 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98516349 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97717882 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95818397 |
| 115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94747110 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94352938 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94113157 |
| 118 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93830212 |
| 119 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93420429 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92172965 |
| 121 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92132057 |
| 122 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91541727 |
| 123 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.90986602 |
| 124 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.90930594 |
| 125 | AR_19668381_ChIP-Seq_PC3_Human | 0.90517846 |
| 126 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90277829 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90032422 |
| 128 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89854263 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89603787 |
| 130 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88354458 |
| 131 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.88278644 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87631151 |
| 133 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.86958137 |
| 134 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86737031 |
| 135 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.86398552 |
| 136 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85792939 |
| 137 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85373289 |
| 138 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84600318 |
| 139 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83976754 |
| 140 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83088338 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83028096 |
| 142 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83028096 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82519755 |
| 144 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.82469791 |
| 145 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82446532 |
| 146 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81796586 |
| 147 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81108271 |
| 148 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81079318 |
| 149 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80712481 |
| 150 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80707416 |
| 151 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.80668881 |
| 152 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80558631 |
| 153 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79895063 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79741666 |
| 155 | KDM2B_26808549_Chip-Seq_K562_Human | 0.79509169 |
| 156 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.79384537 |
| 157 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.79230115 |
| 158 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79125863 |
| 159 | STAT3_23295773_ChIP-Seq_U87_Human | 0.78834482 |
| 160 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78827652 |
| 161 | AR_25329375_ChIP-Seq_VCAP_Human | 0.78558924 |
| 162 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78462014 |
| 163 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78450891 |
| 164 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78061181 |
| 165 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.77937423 |
| 166 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77716674 |
| 167 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.77467894 |
| 168 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77450088 |
| 169 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76896842 |
| 170 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76888502 |
| 171 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.76254106 |
| 172 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.76044101 |
| 173 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.75755954 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.87549320 |
| 2 | MP0002822_catalepsy | 4.22716093 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.15236903 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 3.89903749 |
| 5 | MP0005365_abnormal_bile_salt | 3.59717855 |
| 6 | MP0009840_abnormal_foam_cell | 3.34383574 |
| 7 | MP0004264_abnormal_extraembryonic_tissu | 3.16200281 |
| 8 | MP0004019_abnormal_vitamin_homeostasis | 3.08063579 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.02900226 |
| 10 | MP0005409_darkened_coat_color | 2.83074345 |
| 11 | MP0002254_reproductive_system_inflammat | 2.76499552 |
| 12 | MP0003866_abnormal_defecation | 2.68703637 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.60985503 |
| 14 | MP0003880_abnormal_central_pattern | 2.50547991 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.50224451 |
| 16 | MP0004043_abnormal_pH_regulation | 2.45956674 |
| 17 | MP0009745_abnormal_behavioral_response | 2.45892574 |
| 18 | MP0005670_abnormal_white_adipose | 2.43999428 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.42842024 |
| 20 | MP0009379_abnormal_foot_pigmentation | 2.31271629 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.28336547 |
| 22 | MP0001188_hyperpigmentation | 2.28163984 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.20857059 |
| 24 | MP0003879_abnormal_hair_cell | 2.18666375 |
| 25 | MP0002272_abnormal_nervous_system | 2.08384570 |
| 26 | MP0003172_abnormal_lysosome_physiology | 2.06297403 |
| 27 | MP0002064_seizures | 2.06022146 |
| 28 | MP0001486_abnormal_startle_reflex | 2.00295768 |
| 29 | MP0001440_abnormal_grooming_behavior | 1.99273334 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.96996024 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.91752234 |
| 32 | MP0005332_abnormal_amino_acid | 1.91245334 |
| 33 | MP0004270_analgesia | 1.89777457 |
| 34 | MP0001664_abnormal_digestion | 1.87830458 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.86960144 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.86492372 |
| 37 | MP0001873_stomach_inflammation | 1.85116032 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.83689826 |
| 39 | MP0009046_muscle_twitch | 1.82517780 |
| 40 | MP0001663_abnormal_digestive_system | 1.82476627 |
| 41 | MP0005310_abnormal_salivary_gland | 1.79919041 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.78231556 |
| 43 | MP0003283_abnormal_digestive_organ | 1.75672165 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.74664514 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.68935117 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.67296079 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.65081252 |
| 48 | MP0008569_lethality_at_weaning | 1.63762361 |
| 49 | MP0003252_abnormal_bile_duct | 1.62108384 |
| 50 | MP0008872_abnormal_physiological_respon | 1.61955689 |
| 51 | MP0001970_abnormal_pain_threshold | 1.60166233 |
| 52 | MP0005381_digestive/alimentary_phenotyp | 1.57630776 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.56405570 |
| 54 | MP0000462_abnormal_digestive_system | 1.51351488 |
| 55 | MP0002736_abnormal_nociception_after | 1.51265574 |
| 56 | MP0000538_abnormal_urinary_bladder | 1.50588682 |
| 57 | MP0003828_pulmonary_edema | 1.47706752 |
| 58 | MP0001346_abnormal_lacrimal_gland | 1.44706078 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.37425552 |
| 60 | MP0005451_abnormal_body_composition | 1.34895587 |
| 61 | MP0004742_abnormal_vestibular_system | 1.32991373 |
| 62 | MP0005167_abnormal_blood-brain_barrier | 1.30790373 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.27301628 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.25800890 |
| 65 | MP0001764_abnormal_homeostasis | 1.24022425 |
| 66 | MP0003878_abnormal_ear_physiology | 1.21896392 |
| 67 | MP0005377_hearing/vestibular/ear_phenot | 1.21896392 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.21575652 |
| 69 | MP0002136_abnormal_kidney_physiology | 1.20260967 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.18680551 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.17531086 |
| 72 | MP0001485_abnormal_pinna_reflex | 1.17092794 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.16911956 |
| 74 | MP0002557_abnormal_social/conspecific_i | 1.16092423 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.15943451 |
| 76 | MP0004484_altered_response_of | 1.13919899 |
| 77 | MP0003633_abnormal_nervous_system | 1.10964415 |
| 78 | MP0000678_abnormal_parathyroid_gland | 1.09260484 |
| 79 | MP0002735_abnormal_chemical_nociception | 1.08380038 |
| 80 | MP0008004_abnormal_stomach_pH | 1.07656206 |
| 81 | MP0005448_abnormal_energy_balance | 1.06554553 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.06117729 |
| 83 | MP0001756_abnormal_urination | 1.04858155 |
| 84 | MP0004924_abnormal_behavior | 1.04097249 |
| 85 | MP0005386_behavior/neurological_phenoty | 1.04097249 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 1.02691804 |
| 87 | MP0005423_abnormal_somatic_nervous | 1.02522965 |
| 88 | MP0000609_abnormal_liver_physiology | 1.01370613 |
| 89 | MP0005360_urolithiasis | 1.00493824 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.96232607 |
| 91 | MP0005166_decreased_susceptibility_to | 0.96037632 |
| 92 | MP0002132_abnormal_respiratory_system | 0.95686166 |
| 93 | MP0008874_decreased_physiological_sensi | 0.94101983 |
| 94 | MP0002971_abnormal_brown_adipose | 0.93791808 |
| 95 | MP0010678_abnormal_skin_adnexa | 0.93510011 |
| 96 | MP0005666_abnormal_adipose_tissue | 0.92322804 |
| 97 | MP0001849_ear_inflammation | 0.90580209 |
| 98 | MP0003868_abnormal_feces_composition | 0.89615484 |
| 99 | MP0009115_abnormal_fat_cell | 0.89365293 |
| 100 | MP0003718_maternal_effect | 0.89063759 |
| 101 | MP0003075_altered_response_to | 0.88256936 |
| 102 | MP0009278_abnormal_bone_marrow | 0.87329509 |
| 103 | MP0005535_abnormal_body_temperature | 0.86788117 |
| 104 | MP0000537_abnormal_urethra_morphology | 0.86467027 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.85852909 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.83040865 |
| 107 | MP0009764_decreased_sensitivity_to | 0.82639361 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.81092454 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.79237197 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76881139 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.74908286 |
| 112 | MP0001963_abnormal_hearing_physiology | 0.74560480 |
| 113 | MP0000465_gastrointestinal_hemorrhage | 0.73912441 |
| 114 | MP0004147_increased_porphyrin_level | 0.73635086 |
| 115 | MP0000249_abnormal_blood_vessel | 0.72566845 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.72492351 |
| 117 | MP0002249_abnormal_larynx_morphology | 0.72138519 |
| 118 | MP0000470_abnormal_stomach_morphology | 0.71792644 |
| 119 | MP0005645_abnormal_hypothalamus_physiol | 0.71047604 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.70317406 |
| 121 | MP0004885_abnormal_endolymph | 0.70032697 |
| 122 | MP0008961_abnormal_basal_metabolism | 0.69795639 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.69569568 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.69389362 |
| 125 | MP0000778_abnormal_nervous_system | 0.68649039 |
| 126 | MP0004858_abnormal_nervous_system | 0.68541640 |
| 127 | MP0000490_abnormal_crypts_of | 0.68330935 |
| 128 | MP0003195_calcinosis | 0.67304202 |
| 129 | MP0005636_abnormal_mineral_homeostasis | 0.67202792 |
| 130 | MP0006138_congestive_heart_failure | 0.64809153 |
| 131 | MP0000566_synostosis | 0.64390872 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.64008384 |
| 133 | MP0004947_skin_inflammation | 0.63974558 |
| 134 | MP0004811_abnormal_neuron_physiology | 0.63581210 |
| 135 | MP0003631_nervous_system_phenotype | 0.63443863 |
| 136 | MP0002796_impaired_skin_barrier | 0.63395352 |
| 137 | MP0000613_abnormal_salivary_gland | 0.62958238 |
| 138 | MP0004510_myositis | 0.61607429 |
| 139 | MP0005058_abnormal_lysosome_morphology | 0.61529202 |
| 140 | MP0002069_abnormal_eating/drinking_beha | 0.61217767 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.60937430 |
| 142 | MP0003787_abnormal_imprinting | 0.60171876 |
| 143 | MP0003705_abnormal_hypodermis_morpholog | 0.59073195 |
| 144 | MP0002078_abnormal_glucose_homeostasis | 0.59051134 |
| 145 | MP0000467_abnormal_esophagus_morphology | 0.58984643 |
| 146 | MP0008469_abnormal_protein_level | 0.58526969 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.56867115 |
| 148 | MP0005501_abnormal_skin_physiology | 0.56645323 |
| 149 | MP0003953_abnormal_hormone_level | 0.53029513 |
| 150 | MP0002998_abnormal_bone_remodeling | 0.52005344 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.51377286 |
| 152 | MP0009785_altered_susceptibility_to | 0.50566377 |
| 153 | MP0003045_fibrosis | 0.49707420 |
| 154 | MP0005334_abnormal_fat_pad | 0.48895401 |
| 155 | MP0002089_abnormal_postnatal_growth/wei | 0.47807482 |
| 156 | MP0005375_adipose_tissue_phenotype | 0.47318440 |
| 157 | MP0005025_abnormal_response_to | 0.46296396 |
| 158 | MP0005395_other_phenotype | 0.45684048 |
| 159 | MP0003436_decreased_susceptibility_to | 0.43157199 |
| 160 | MP0000604_amyloidosis | 0.43011292 |
| 161 | MP0005023_abnormal_wound_healing | 0.41309139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 9.32973549 |
| 2 | Malnutrition (HP:0004395) | 6.85526508 |
| 3 | Hydroxyprolinuria (HP:0003080) | 6.60641888 |
| 4 | Abnormality of proline metabolism (HP:0010907) | 6.60641888 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.43257179 |
| 6 | Scanning speech (HP:0002168) | 6.34831813 |
| 7 | Metabolic alkalosis (HP:0200114) | 6.19621274 |
| 8 | Myokymia (HP:0002411) | 4.91559674 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.90387993 |
| 10 | Focal motor seizures (HP:0011153) | 4.55324452 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 4.41963065 |
| 12 | Pustule (HP:0200039) | 4.39321169 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.38092891 |
| 14 | Abnormality of renin-angiotensin system (HP:0000847) | 4.33038208 |
| 15 | Right ventricular cardiomyopathy (HP:0011663) | 4.30465632 |
| 16 | Increased circulating renin level (HP:0000848) | 4.15862396 |
| 17 | Esophageal atresia (HP:0002032) | 4.12647167 |
| 18 | Distal lower limb muscle weakness (HP:0009053) | 4.07847034 |
| 19 | Fat malabsorption (HP:0002630) | 3.97005055 |
| 20 | Widely patent fontanelles and sutures (HP:0004492) | 3.95511415 |
| 21 | Abnormality of chloride homeostasis (HP:0011422) | 3.90694753 |
| 22 | Hemorrhage of the eye (HP:0011885) | 3.85995129 |
| 23 | Thin bony cortex (HP:0002753) | 3.82994655 |
| 24 | Hyperaldosteronism (HP:0000859) | 3.77603264 |
| 25 | Hyperglycinuria (HP:0003108) | 3.69165752 |
| 26 | Confusion (HP:0001289) | 3.63946027 |
| 27 | Syncope (HP:0001279) | 3.61382946 |
| 28 | Xanthomatosis (HP:0000991) | 3.60744125 |
| 29 | Complement deficiency (HP:0004431) | 3.58943928 |
| 30 | Abnormality of binocular vision (HP:0011514) | 3.49180020 |
| 31 | Diplopia (HP:0000651) | 3.49180020 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 3.48970751 |
| 33 | Proximal tubulopathy (HP:0000114) | 3.41013854 |
| 34 | Ileus (HP:0002595) | 3.34941700 |
| 35 | Abnormality of complement system (HP:0005339) | 3.33796499 |
| 36 | Prolonged QT interval (HP:0001657) | 3.30430267 |
| 37 | Decreased circulating renin level (HP:0003351) | 3.24478319 |
| 38 | Epileptic encephalopathy (HP:0200134) | 3.19537097 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 3.19406670 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.19406670 |
| 41 | Large eyes (HP:0001090) | 3.17716656 |
| 42 | Bundle branch block (HP:0011710) | 3.14769474 |
| 43 | Potter facies (HP:0002009) | 3.07041569 |
| 44 | Facial shape deformation (HP:0011334) | 3.07041569 |
| 45 | Acanthocytosis (HP:0001927) | 3.04875627 |
| 46 | Chronic diarrhea (HP:0002028) | 3.03548585 |
| 47 | Pigmentary retinal degeneration (HP:0001146) | 3.02405051 |
| 48 | Glomerulonephritis (HP:0000099) | 3.02264074 |
| 49 | Poor eye contact (HP:0000817) | 3.01181403 |
| 50 | Wide cranial sutures (HP:0010537) | 3.00017523 |
| 51 | Focal seizures (HP:0007359) | 2.99579703 |
| 52 | Focal segmental glomerulosclerosis (HP:0000097) | 2.97429518 |
| 53 | Tetany (HP:0001281) | 2.94804256 |
| 54 | Nephrolithiasis (HP:0000787) | 2.93102630 |
| 55 | Ventricular fibrillation (HP:0001663) | 2.92678957 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.91749405 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.90298361 |
| 58 | Increased purine levels (HP:0004368) | 2.84804209 |
| 59 | Hyperuricemia (HP:0002149) | 2.84804209 |
| 60 | Abnormal social behavior (HP:0012433) | 2.82570592 |
| 61 | Impaired social interactions (HP:0000735) | 2.82570592 |
| 62 | Hypophosphatemia (HP:0002148) | 2.78433975 |
| 63 | Progressive visual loss (HP:0000529) | 2.77741476 |
| 64 | Abnormal EKG (HP:0003115) | 2.71110391 |
| 65 | Febrile seizures (HP:0002373) | 2.69546551 |
| 66 | Clumsiness (HP:0002312) | 2.65864954 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.65266037 |
| 68 | Glycosuria (HP:0003076) | 2.65266037 |
| 69 | Nephritis (HP:0000123) | 2.63982419 |
| 70 | Increased cerebral lipofuscin (HP:0011813) | 2.63473769 |
| 71 | Nausea (HP:0002018) | 2.63373430 |
| 72 | Abnormality of magnesium homeostasis (HP:0004921) | 2.63094833 |
| 73 | Alkalosis (HP:0001948) | 2.62414019 |
| 74 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.61346766 |
| 75 | Cerebral palsy (HP:0100021) | 2.57446971 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.54734874 |
| 77 | Progressive cerebellar ataxia (HP:0002073) | 2.51585920 |
| 78 | Steatorrhea (HP:0002570) | 2.50443890 |
| 79 | Hypokalemia (HP:0002900) | 2.49690730 |
| 80 | Abnormality of DNA repair (HP:0003254) | 2.45850569 |
| 81 | Gout (HP:0001997) | 2.44699522 |
| 82 | Villous atrophy (HP:0011473) | 2.43616276 |
| 83 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.43616276 |
| 84 | Hypolipoproteinemia (HP:0010981) | 2.43499533 |
| 85 | Short chin (HP:0000331) | 2.43035367 |
| 86 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41856371 |
| 87 | Intention tremor (HP:0002080) | 2.41426437 |
| 88 | Action tremor (HP:0002345) | 2.40606486 |
| 89 | Visual hallucinations (HP:0002367) | 2.40552394 |
| 90 | Abnormality of vitamin B metabolism (HP:0004340) | 2.39289267 |
| 91 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39108172 |
| 92 | Alopecia of scalp (HP:0002293) | 2.37913272 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.37848581 |
| 94 | Abnormal drinking behavior (HP:0030082) | 2.36811285 |
| 95 | Polydipsia (HP:0001959) | 2.36811285 |
| 96 | Progressive hearing impairment (HP:0001730) | 2.33605033 |
| 97 | Adrenal overactivity (HP:0002717) | 2.32593006 |
| 98 | Impaired platelet aggregation (HP:0003540) | 2.29491162 |
| 99 | Abnormal platelet function (HP:0011869) | 2.29491162 |
| 100 | Flat acetabular roof (HP:0003180) | 2.28658808 |
| 101 | Hyperammonemia (HP:0001987) | 2.27586880 |
| 102 | Abnormality of the 1st metacarpal (HP:0010009) | 2.27043962 |
| 103 | Atonic seizures (HP:0010819) | 2.26434771 |
| 104 | Protuberant abdomen (HP:0001538) | 2.26388107 |
| 105 | Broad-based gait (HP:0002136) | 2.26178709 |
| 106 | Intrahepatic cholestasis (HP:0001406) | 2.25682752 |
| 107 | Hypotension (HP:0002615) | 2.25500037 |
| 108 | Glomerulosclerosis (HP:0000096) | 2.25134354 |
| 109 | Hyperparathyroidism (HP:0000843) | 2.24260937 |
| 110 | Abdominal distention (HP:0003270) | 2.23098806 |
| 111 | Gastrointestinal atresia (HP:0002589) | 2.21798450 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 2.17960967 |
| 113 | Gastrointestinal dysmotility (HP:0002579) | 2.17887869 |
| 114 | Hypokalemic alkalosis (HP:0001949) | 2.15193886 |
| 115 | Axonal loss (HP:0003447) | 2.14256751 |
| 116 | Ventricular arrhythmia (HP:0004308) | 2.13602901 |
| 117 | Heart block (HP:0012722) | 2.13219631 |
| 118 | Eczematoid dermatitis (HP:0000976) | 2.10958188 |
| 119 | Abnormal atrioventricular conduction (HP:0005150) | 2.10893040 |
| 120 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10181870 |
| 121 | Dysmetria (HP:0001310) | 2.09095421 |
| 122 | Neonatal short-limb short stature (HP:0008921) | 2.07535447 |
| 123 | Hypomagnesemia (HP:0002917) | 2.06099537 |
| 124 | Dysdiadochokinesis (HP:0002075) | 2.04073898 |
| 125 | Postural tremor (HP:0002174) | 2.03713251 |
| 126 | Abnormality of potassium homeostasis (HP:0011042) | 2.01961214 |
| 127 | Anxiety (HP:0000739) | 2.00934568 |
| 128 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.00272150 |
| 129 | Genetic anticipation (HP:0003743) | 1.99960291 |
| 130 | Lower limb amyotrophy (HP:0007210) | 1.99354440 |
| 131 | Gingivitis (HP:0000230) | 1.98995418 |
| 132 | Relative macrocephaly (HP:0004482) | 1.98914730 |
| 133 | Decreased subcutaneous fat (HP:0001002) | 1.98208994 |
| 134 | Hypoplasia of dental enamel (HP:0006297) | 1.97878090 |
| 135 | Late onset (HP:0003584) | 1.97822732 |
| 136 | Pancreatitis (HP:0001733) | 1.97735272 |
| 137 | Enlarged epiphyses (HP:0010580) | 1.97632104 |
| 138 | Megaloblastic anemia (HP:0001889) | 1.96546213 |
| 139 | Cheilitis (HP:0100825) | 1.95261436 |
| 140 | Dehydration (HP:0001944) | 1.94301692 |
| 141 | Abnormality of the preputium (HP:0100587) | 1.93297547 |
| 142 | Abnormal urine phosphate concentration (HP:0012599) | 1.92675346 |
| 143 | Symptomatic seizures (HP:0011145) | 1.89286647 |
| 144 | Distal lower limb amyotrophy (HP:0008944) | 1.87911759 |
| 145 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87798539 |
| 146 | Metabolic acidosis (HP:0001942) | 1.86916790 |
| 147 | Hyperphosphatemia (HP:0002905) | 1.86845752 |
| 148 | Optic neuritis (HP:0100653) | 1.86444367 |
| 149 | Retrobulbar optic neuritis (HP:0100654) | 1.86444367 |
| 150 | Keratoconjunctivitis (HP:0001096) | 1.86178578 |
| 151 | Methylmalonic acidemia (HP:0002912) | 1.85869255 |
| 152 | Xerostomia (HP:0000217) | 1.85169899 |
| 153 | Abnormal glucose tolerance (HP:0001952) | 1.84849120 |
| 154 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84491701 |
| 155 | Dicarboxylic aciduria (HP:0003215) | 1.84491701 |
| 156 | Broad metatarsal (HP:0001783) | 1.84290073 |
| 157 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.84057870 |
| 158 | Ankyloglossia (HP:0010296) | 1.83802429 |
| 159 | Bronchomalacia (HP:0002780) | 1.83214773 |
| 160 | Abnormality of the corticospinal tract (HP:0002492) | 1.82298352 |
| 161 | Rectal prolapse (HP:0002035) | 1.81516911 |
| 162 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80653981 |
| 163 | Pili torti (HP:0003777) | 1.80138942 |
| 164 | Delayed epiphyseal ossification (HP:0002663) | 1.79741092 |
| 165 | Hyperventilation (HP:0002883) | 1.79709848 |
| 166 | Onycholysis (HP:0001806) | 1.78936659 |
| 167 | Plantar hyperkeratosis (HP:0007556) | 1.77730198 |
| 168 | Abnormality of vitamin metabolism (HP:0100508) | 1.77386978 |
| 169 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76527865 |
| 170 | Posterior subcapsular cataract (HP:0007787) | 1.73872079 |
| 171 | Abnormal hair laboratory examination (HP:0003328) | 1.71664154 |
| 172 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.68142208 |
| 173 | Myopathic facies (HP:0002058) | 1.65530274 |
| 174 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.65091988 |
| 175 | Emphysema (HP:0002097) | 1.64982514 |
| 176 | Subcapsular cataract (HP:0000523) | 1.63462872 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 7.52282771 |
| 2 | ACVR1B | 5.66625756 |
| 3 | SIK2 | 4.98786553 |
| 4 | ERN1 | 4.35147056 |
| 5 | SIK1 | 3.96443038 |
| 6 | EPHA2 | 3.76393164 |
| 7 | MST4 | 3.55223628 |
| 8 | ADRBK2 | 3.05593978 |
| 9 | MET | 2.90091824 |
| 10 | NTRK3 | 2.90016370 |
| 11 | TAOK3 | 2.78336970 |
| 12 | TYRO3 | 2.64851430 |
| 13 | EPHA4 | 2.64426373 |
| 14 | TAOK1 | 2.45984804 |
| 15 | FGFR4 | 2.45281514 |
| 16 | MAP3K10 | 2.39674864 |
| 17 | MARK3 | 2.35947721 |
| 18 | KSR2 | 2.12991163 |
| 19 | EPHB2 | 2.05432864 |
| 20 | MAP3K9 | 2.04004058 |
| 21 | LMTK2 | 1.91940698 |
| 22 | SGK3 | 1.91771943 |
| 23 | TRIB3 | 1.80478213 |
| 24 | RIPK4 | 1.72175448 |
| 25 | DDR2 | 1.70238052 |
| 26 | EPHB1 | 1.61796007 |
| 27 | TNIK | 1.60704525 |
| 28 | STK39 | 1.52598894 |
| 29 | MAP3K12 | 1.37734916 |
| 30 | EPHA3 | 1.29694875 |
| 31 | NME1 | 1.28854453 |
| 32 | TYK2 | 1.20978251 |
| 33 | MAP3K13 | 1.19504486 |
| 34 | ERBB2 | 1.19314933 |
| 35 | KSR1 | 1.15884702 |
| 36 | MAP4K1 | 1.15771544 |
| 37 | CDK12 | 1.14599147 |
| 38 | PRKG2 | 1.14429013 |
| 39 | DAPK2 | 1.13715078 |
| 40 | SGK2 | 1.12186265 |
| 41 | ICK | 1.08941012 |
| 42 | PIK3CA | 1.08917578 |
| 43 | SGK223 | 1.04768582 |
| 44 | SGK494 | 1.04768582 |
| 45 | MARK2 | 1.00616099 |
| 46 | MST1R | 1.00195621 |
| 47 | CASK | 0.97599004 |
| 48 | FGFR3 | 0.97138545 |
| 49 | TAOK2 | 0.95371515 |
| 50 | PRKAA2 | 0.93558470 |
| 51 | CDK19 | 0.90882260 |
| 52 | MAP2K2 | 0.89228510 |
| 53 | PDK3 | 0.88790568 |
| 54 | PDK4 | 0.88790568 |
| 55 | NLK | 0.87624396 |
| 56 | PDGFRA | 0.87359634 |
| 57 | AKT3 | 0.86880053 |
| 58 | PRPF4B | 0.85446278 |
| 59 | PAK6 | 0.84710019 |
| 60 | TESK2 | 0.82503857 |
| 61 | FRK | 0.81118698 |
| 62 | CDC42BPA | 0.78369694 |
| 63 | MAP3K7 | 0.78130061 |
| 64 | MAP2K7 | 0.77611507 |
| 65 | PTK2 | 0.75993968 |
| 66 | BMX | 0.75782508 |
| 67 | STK24 | 0.74565975 |
| 68 | MAP3K1 | 0.72256033 |
| 69 | GRK6 | 0.72039895 |
| 70 | MAP3K2 | 0.70417441 |
| 71 | MINK1 | 0.69710070 |
| 72 | MAP2K6 | 0.68401099 |
| 73 | MAPK11 | 0.68265115 |
| 74 | BMPR2 | 0.67566884 |
| 75 | DMPK | 0.64018661 |
| 76 | CDK5 | 0.63392403 |
| 77 | MYLK | 0.63067822 |
| 78 | TNK2 | 0.62610696 |
| 79 | CAMK2B | 0.61815562 |
| 80 | CAMK1 | 0.61760626 |
| 81 | ADRBK1 | 0.60553613 |
| 82 | SMG1 | 0.59327086 |
| 83 | CAMK2A | 0.59281369 |
| 84 | OXSR1 | 0.57417512 |
| 85 | MAP3K4 | 0.57243431 |
| 86 | PAK3 | 0.57107187 |
| 87 | RPS6KA2 | 0.55360478 |
| 88 | TESK1 | 0.54784711 |
| 89 | MAP2K1 | 0.53717073 |
| 90 | PRKACG | 0.53242725 |
| 91 | EEF2K | 0.52066200 |
| 92 | MAP3K11 | 0.51812870 |
| 93 | CAMK2D | 0.51050956 |
| 94 | CAMKK1 | 0.50761209 |
| 95 | PDPK1 | 0.50711192 |
| 96 | SGK1 | 0.48563212 |
| 97 | PDK1 | 0.48089849 |
| 98 | PAK4 | 0.47935323 |
| 99 | ZAP70 | 0.46377696 |
| 100 | TBK1 | 0.46144961 |
| 101 | PRKCG | 0.46108904 |
| 102 | PKN2 | 0.45877880 |
| 103 | DAPK1 | 0.44996220 |
| 104 | CAMK2G | 0.44510909 |
| 105 | PDK2 | 0.43958584 |
| 106 | MAP2K4 | 0.42495170 |
| 107 | RET | 0.41419767 |
| 108 | RIPK1 | 0.41174697 |
| 109 | RAF1 | 0.40683391 |
| 110 | NEK6 | 0.40535335 |
| 111 | MAPKAPK5 | 0.40282517 |
| 112 | RPS6KB2 | 0.39426661 |
| 113 | PRKCZ | 0.39317691 |
| 114 | WNK1 | 0.39215237 |
| 115 | MAPK7 | 0.38741226 |
| 116 | DYRK1B | 0.36491330 |
| 117 | MELK | 0.36373006 |
| 118 | PRKCI | 0.36247109 |
| 119 | RPS6KC1 | 0.36205600 |
| 120 | RPS6KL1 | 0.36205600 |
| 121 | PRKCE | 0.35972400 |
| 122 | STK10 | 0.34871064 |
| 123 | TXK | 0.34396770 |
| 124 | KDR | 0.33886825 |
| 125 | RPS6KA6 | 0.33596025 |
| 126 | HIPK2 | 0.33207412 |
| 127 | MTOR | 0.33115050 |
| 128 | MATK | 0.32935120 |
| 129 | STK38 | 0.32769558 |
| 130 | MAP3K6 | 0.32186047 |
| 131 | FES | 0.31239967 |
| 132 | PRKCA | 0.30722606 |
| 133 | PRKD2 | 0.30571519 |
| 134 | CSF1R | 0.30562971 |
| 135 | PRKAA1 | 0.30304088 |
| 136 | GRK1 | 0.29992564 |
| 137 | TEC | 0.28976164 |
| 138 | CSNK1A1 | 0.28711486 |
| 139 | IRAK1 | 0.27964724 |
| 140 | STK11 | 0.27862068 |
| 141 | IKBKE | 0.27833845 |
| 142 | NTRK2 | 0.27527176 |
| 143 | ALK | 0.27084125 |
| 144 | FYN | 0.26882961 |
| 145 | KIT | 0.26545847 |
| 146 | MAPKAPK2 | 0.26158053 |
| 147 | PDGFRB | 0.25896624 |
| 148 | SRC | 0.25490806 |
| 149 | PRKCH | 0.25214460 |
| 150 | MAP3K3 | 0.24801040 |
| 151 | CHUK | 0.23950819 |
| 152 | PRKD3 | 0.23875610 |
| 153 | MAP2K3 | 0.23809943 |
| 154 | MAPK13 | 0.23416465 |
| 155 | AKT2 | 0.22694927 |
| 156 | FER | 0.20977236 |
| 157 | INSRR | 0.20917351 |
| 158 | JAK1 | 0.20868846 |
| 159 | PTK6 | 0.19454005 |
| 160 | PRKCQ | 0.19446028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.00590746 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.73907729 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.51090352 |
| 4 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.46467418 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.32479958 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28512178 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.25028504 |
| 8 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.11060477 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.10890094 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.09725970 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03544408 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02565168 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.01893706 |
| 14 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.00550315 |
| 15 | Mineral absorption_Homo sapiens_hsa04978 | 2.00356428 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 2.00266123 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 1.99265306 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.91330817 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.88436209 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.86537876 |
| 21 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86249263 |
| 22 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.84758226 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.83485559 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82458185 |
| 25 | Olfactory transduction_Homo sapiens_hsa04740 | 1.80027976 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75041559 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74219387 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68300630 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65219690 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60602584 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57858059 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.51919730 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45784831 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44369720 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.43799091 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.42701034 |
| 37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.41601114 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.41517888 |
| 39 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.41261814 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.41224660 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.40270042 |
| 42 | Taste transduction_Homo sapiens_hsa04742 | 1.39893172 |
| 43 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.37743256 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 1.27260880 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.26465672 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26148599 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.25233888 |
| 48 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25227643 |
| 49 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23368962 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20674504 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19335631 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.17321405 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.15260236 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14717483 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14566763 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 1.13478844 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11165191 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11152558 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 1.07997033 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04599383 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.04101437 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02192849 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02145018 |
| 64 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.00870058 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99309863 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98394252 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97089848 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95000256 |
| 69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94642798 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93009435 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89475655 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88907086 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87669847 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.87185457 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.86428686 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85782765 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82067673 |
| 78 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81979312 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79110995 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76579902 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76353178 |
| 82 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76044565 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.75397266 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.74010745 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73652268 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.70701190 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68358466 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66215118 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.64750120 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64620023 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.63974300 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.63513359 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62222961 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61729769 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61415301 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61057911 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60903586 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60510429 |
| 99 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58064168 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.57524807 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.57408627 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57304453 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56968083 |
| 104 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55422589 |
| 105 | Allograft rejection_Homo sapiens_hsa05330 | 0.53092880 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50744694 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.50690034 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.49241606 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48974156 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48488603 |
| 111 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48249508 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45116633 |
| 113 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44760643 |
| 114 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44241530 |
| 115 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44023506 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44018278 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.41485488 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.41279034 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38794494 |
| 120 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38743958 |
| 121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37920665 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.36515069 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35493729 |
| 124 | Melanogenesis_Homo sapiens_hsa04916 | 0.34207945 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.33048540 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31677884 |
| 127 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29944964 |
| 128 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.29137576 |
| 129 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28460390 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.27522159 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27284841 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.26900427 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | 0.25541783 |
| 134 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25509518 |
| 135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25124430 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24672562 |
| 137 | Pertussis_Homo sapiens_hsa05133 | 0.24586184 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.23424253 |
| 139 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23412662 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.23229747 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22321656 |
| 142 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22300393 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22145666 |
| 144 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20910232 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20092445 |
| 146 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.19079069 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.17380617 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.15643704 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.14255481 |
| 150 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.14135858 |
| 151 | Carbon metabolism_Homo sapiens_hsa01200 | 0.12263095 |
| 152 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12115551 |
| 153 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.11799645 |
| 154 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11535543 |

